Indian healthcare leaders convened recently to address the escalating crisis of hospital-acquired infections (HAIs), outlining a multifaceted strategy aligned with national and global goals to ensure safer hospitals by 2030. In a pivotal fireside chat on January 16, 2026, experts emphasized infrastructure upgrades, technology integration, and cultural shifts to combat HAIs, which claim around 80,000 lives annually amid 2 million cases nationwide. This push responds to post-COVID vulnerabilities and antimicrobial resistance (AMR), positioning infection prevention and control (IPC) as a cornerstone of public health resilience.
Key Developments from Expert Dialogue
Dr. Shashikant Pawar, CEO of Kokilaben Dhirubhai Ambani Hospital, highlighted that India’s IPC efforts align with the World Health Organization’s (WHO) Global Action Plan and Monitoring Framework for IPC (2024-2030), alongside national policies targeting universal safety in healthcare access and delivery by decade’s end. Dr. Prasanna Venkatesh, Managing Director of NU Hospitals, noted progress in controlling surgical site infections and ICU hotspots but stressed persistent environmental threats as a core HAI factor, requiring vigilant monitoring. The discussion underscored a shocking gap: no new antibiotic class developed in 40 years, amplifying urgency for prevention over treatment.
These insights emerged from a leadership-focused conversation bridging alarming statistics—such as over 300,000 annual deaths from drug-resistant infections—with practical pathways forward. Attendees gained actionable takeaways on real-time surveillance and accountability, reflecting a shift from reactive to proactive hospital ecosystems.
Current Challenges and Ground Realities
HAIs affect up to 10% of patients in developing countries like India, prolonging stays, escalating costs, and fueling AMR, where bacteria resist nearly all antibiotics in some cases. In India, approximately 70,000 hospitals exist, but only 3,000-4,000 are accredited, revealing a vast quality chasm despite decade-long improvements. Tertiary centers face heightened risks, with critically ill patients demanding clinician-microbiologist collaboration and nurse involvement to track antibiotic efficacy.
Environmental security remains elusive; while surgical and high-risk areas show gains, air, water, and surface contamination persist without robust checks. Workforce shortages compound issues, as skilled IPC personnel are scarce, though fostering a hospital-wide “no blame” culture could empower existing teams. AMR exacerbates this, with E. coli carbapenem resistance rising from 10% in 2008 to 13% by 2013 in surveillance data.
Technological and Policy Innovations
India’s National Guidelines for IPC in Healthcare Facilities (2020), developed by the National Centre for Disease Control (NCDC) with WHO support, form the bedrock, advocating standard precautions like hand hygiene and bundle approaches for device-related infections. Leaders spotlight AI-driven tools: IoT sensors in operating theaters monitor air quality, positive pressure, and sterilization, with apps delivering real-time alerts. Predictive analytics and real-time location sensing promise further leaps, automating surveillance to curb HAIs proactively.
Policy-wise, integration into medical and nursing curricula is emerging, alongside SOPs, protocols, and outcome analysis under the National Patient Safety Implementation Framework (2018-2025). The National Action Plan on AMR prioritizes IPC as its third pillar, linking it to reduced antibiotic needs. Accreditation bodies like NABH enforce surveillance, with networks like AIIMS-ICMR tracking trends across 35 centers.
Expert Perspectives
“Infection control isn’t a single department; it is a mindset and working culture built on transparency and accountability,” Dr. Venkatesh asserted, urging internal alerts to foster early contamination detection. Dr. Pawar echoed, questioning workforce strategies: train existing staff or hire specialists? Venkatesh advocated culture-building for all.
Independent experts reinforce this. Dr. Suhas M.S. remains optimistic: “With strengthened national programs, AI tools, hygiene improvements, and data-driven tactics, India can mitigate pathogen spread.” WHO India stresses IPC’s evidence-based role in averting harm, supporting MoHFW policies and training. NCDC Director Dr. Sujeet K. Singh notes IPC’s centrality to safe environments, reducing AMR via surveillance.
Public Health Implications
Robust IPC could slash India’s 2 million annual HAIs, saving lives, cutting costs, and curbing AMR, which burdens ICUs with multidrug-resistant organisms. Patients benefit from safer stays; providers from reduced occupational risks via PPE, vaccinations, and training. Daily decisions shift: demand accredited facilities, practice hand hygiene (simplest intervention), and support antibiotic stewardship.
Nationally, this aligns with Swachh Bharat and Kayakalp, enhancing resilience against outbreaks like Nipah. Globally, it advances SDG targets for sanitation and AMR containment.
Limitations and Counterarguments
Challenges persist: resource gaps in non-accredited hospitals hinder implementation, and manpower shortages demand scaled training. Technology adoption varies; rural facilities lag in AI/IoT access. Optimism on curricula integration is tempered—”slowly creeping in”—risking uneven preparedness.
Critics note surveillance limits to accredited sites, underestimating true HAI burden. Yet, multimodal strategies—guidelines, audits, feedback—offer scalable fixes, per WHO core components.
Practical Advice for Readers
Healthcare consumers: Verify NABH accreditation, inquire about IPC protocols, and prioritize hand hygiene—alcohol-based rubs cut transmission effectively. Providers: Embed bundles for ventilators (VAP prevention), catheters (CAUTI/CLABSI), elevating heads 30-45 degrees and daily chlorhexidine washes. Facilities: Form IPC committees, audit compliance, and leverage digital tools for surveillance.
References
-
Venkatesh P, Pawar S. India goes robust on the future of infection prevention. The Economic Times Health, January 16, 2026. https://health.economictimes.indiatimes.com/news/industry/india-goes-robust-on-the-future-of-infection-prevention/126564779[health.economictimes.indiatimes]
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.